Insider trading

Period: 120 months Stock: ANNX Role: Other officers × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

35 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

35 decisions over 120 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

35 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

35 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
35 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
35 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

35 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
2 Mar 2026
ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER
Sold at will
$32.00K 5,894 at 5.43
3.2%
Not planned
2 Mar 2026
Dananberg Jamie CHIEF MEDICAL OFFICER
Sold at will
$31.60K 5,820 at 5.43
4.5%
Not planned
2 Mar 2026
Yednock Ted EVP & CHIEF INNOVATION OFFICER
Sold at will
$30.17K 5,566 at 5.42
3.5%
Not planned
2 Mar 2026
Overdorf Michael EVP & CHIEF BUSINESS OFFICER
Sold at will
$23.52K 4,339 at 5.42
2.3%
Not planned
18 Feb 2026
Yednock Ted EVP & CHIEF INNOVATION OFFICER
Sold at will
$40.15K 7,857 at 5.11
7.5%
Not planned
18 Feb 2026
Overdorf Michael EVP & CHIEF BUSINESS OFFICER
Sold at will
$31.75K 6,225 at 5.10
4.8%
Not planned
18 Feb 2026
ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER
Sold at will
$26.98K 5,290 at 5.10
4.1%
Not planned
18 Feb 2026
Dananberg Jamie CHIEF MEDICAL OFFICER
Sold at will
$26.98K 5,290 at 5.10
6.7%
Not planned
14 Jul 2025
Yednock Ted EVP & CHIEF INNOVATION OFFICER
Sold at will
$2.88K 1,116 at 2.58
1.1%
Not planned
14 Jul 2025
Overdorf Michael EVP & CHIEF BUSINESS OFFICER
Sold at will
$2.23K 853 at 2.61
0.6%
Not planned
18 Feb 2025
Yednock Ted EVP & CHIEF INNOVATION OFFICER
Sold at will
$24.28K 8,345 at 2.91
12.0%
Not planned
18 Feb 2025
Overdorf Michael EVP & CHIEF BUSINESS OFFICER
Sold at will
$19.52K 6,618 at 2.95
7.1%
Not planned
18 Feb 2025
ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER
Sold at will
$16.38K 5,515 at 2.97
6.2%
Not planned
18 Feb 2025
Dananberg Jamie CHIEF MEDICAL OFFICER
Sold at will
$16.34K 5,521 at 2.96
14.2%
Not planned
13 Feb 2025
Yednock Ted EVP & CHIEF INNOVATION OFFICER
Sold at will
$5.33K 1,783 at 2.99
2.5%
Not planned
13 Feb 2025
Overdorf Michael EVP & CHIEF BUSINESS OFFICER
Sold at will
$4.26K 1,425 at 2.99
1.5%
Not planned
15 Oct 2024
Yednock Ted EVP & CHIEF INNOVATION OFFICER
Sold on a plan
$40.07K 5,408 at 7.41
7.0%
Planned (10b5-1)
19 Sep 2024
Yednock Ted EVP & CHIEF INNOVATION OFFICER · indirect
Sold on a plan
$31.95K 4,500 at 7.10
100%
Sold half or more
12 Sep 2024
Yednock Ted EVP & CHIEF INNOVATION OFFICER · indirect
Sold on a plan
$33.88K 5,500 at 6.16
55.0%
Sold half or more
5 Sep 2024
Yednock Ted EVP & CHIEF INNOVATION OFFICER · indirect
Sold on a plan
$31.02K 5,500 at 5.64
35.5%
Planned (10b5-1)
29 Aug 2024
Yednock Ted EVP & CHIEF INNOVATION OFFICER · indirect
Sold on a plan
$32.73K 5,500 at 5.95
26.2%
Planned (10b5-1)
15 Jul 2024
Yednock Ted EVP & CHIEF INNOVATION OFFICER
Sold at will
$6.66K 1,106 at 6.02
1.5%
Not planned
15 Jul 2024
Overdorf Michael EVP & CHIEF BUSINESS OFFICER
Sold at will
$4.72K 784 at 6.02
0.8%
Not planned
20 Feb 2024
Yednock Ted EVP & CHIEF INNOVATION OFFICER
Sold at will
$14.35K 2,604 at 5.51
3.5%
Not planned
20 Feb 2024
Overdorf Michael EVP & CHIEF BUSINESS OFFICER
Sold at will
$10.69K 1,951 at 5.48
2.2%
Not planned
12 Feb 2024
Yednock Ted EVP & CHIEF INNOVATION OFFICER
Sold at will
$10.03K 1,810 at 5.54
4.8%
Not planned
12 Feb 2024
Overdorf Michael EVP & CHIEF BUSINESS OFFICER
Sold at will
$7.46K 1,349 at 5.53
2.7%
Not planned
27 Dec 2023
Yednock Ted EVP & Chief Innovation Officer
Sold on a plan
$94.97K 21,000 at 4.52
100%
Sold half or more
11 Jul 2023
Overdorf Michael EVP & Chief Business Officer
Sold at will
$3.75K 978 at 3.84
2.1%
Not planned
14 Feb 2023
Overdorf Michael EVP & Chief Business Officer
Sold, plan not stated
$907.10 144 at 6.30
0.5%
13 Feb 2023
Overdorf Michael EVP & Chief Business Officer
Sold, plan not stated
$9.46K 1,501 at 6.30
5.1%
13 Sep 2021
Yednock Ted EVP & Chief Scientific Officer
Sold, plan not stated
$323.86K 16,190 at 20.00
100%
Sold half or more
3 Jun 2021
Yednock Ted EVP & Chief Scientific Officer
Sold, plan not stated 2×
$322.32K 15,000 at 21.49
100%
Sold half or more
25 Mar 2021
Yednock Ted EVP & Chief Scientific Officer
Sold, plan not stated 3×
$465.77K 16,175 at 28.80
100%
Sold half or more
24 Mar 2021
Keswani Sanjay Chandru EVP & Chief Medical Officer
Sold, plan not stated
$120.51K 3,995 at 30.17
100%
Sold half or more
Showing 1–35 of 35.